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Hereditary nephritis associated with May Hegglin's anomaly. F.
Brivet, C. Barbanel, R. Girot, C. Gazengel, M. Maier, J. Cros-
flier. Necker Hospital, Paris, France. Hereditary nephritis (HN)
is occasionally associated with deafness and/or ocular defects.
Its association with hematologic abnormalities seems ex-
ceptional. We have observed a family in which nephritis was as-
sociated with May Hegglin's syndrome (MHS). A 9-year-old girl
presented with proteinuria, microscopic hematuria, and arterial
hypertension. Her father has proteinuria. Her paternal uncle re-
ceived a kidney graft. A paternal grand-aunt died on periodic
hemodialysis. Neither the girl nor her father have ocular abnor-
malities or hearing loss on audiogram. The uncle and the grand
aunt had no clinical deafness. The girl, her father, and uncle
present macrothrombocytopenia (40 to 10 l0 platelets/cu mm,
size 4 to 8 ) with Döhle bodies in neutrophils. Despite normal in
vitro platelet functions, the girl and her father have prolonged
bleeding time, which precluded renal biopsy. The three living
propositus share the HLA A2 B17 haplotype. The combined syn-
drome of HN and macrothrombocytopenia with or without ab-
normal in vitro platelet functions has been described. HN associ-
ated with macrothrombocytopenia and Döhle bodies in neutro-
phils (MHS) has not been previously reported.
Relationship between change in volemia at constant osmolality and
plasma antidiuretic hormone. H. Caillens, W. Pruszczynski, K. S.
Ang, A. Meyrier, and R. Ardaillou. INSERM 64, Hópital Tenon,
Paris, France. The relationship between change in volemia at
constant osmolality and plasma antidiuretic hormone (ADH) was
studied in uremic patients during hemofiltration sessions. The
threshold for ADH secretion corresponded to a loss of 320 ml of
water. Plasma ADH then increased by an average of 0.55 pg/mI
for each 100 ml of plasma water ultrafiltered. In bilaterally ne-
phrectomized patients, the threshold was greater (820 ml) and
the slope smaller (0.24 pg/mI per 100 ml water lost). The slope
also diminished in non-nephretomized patients after ingestion of
an inhibitor of angiotensin II (All) converting enzyme. When
0.16 M sodium chloride was administered after a marked deple-
tion had been obtained, in an amount and a rate equivalent to
those of the loss of plasma water, plasma ADH first fell rapidly
and then more slowly. Change of slope occurred after 800 ml of
saline had been infused. Ultrafiltration of the same amount of
water produced a marked or a slight increase in plasma ADH
according to whether hemodialysis with subsequent fall in
plasma osmolality had or had not been associated to hemo-
filtration. Administration of hypertonic 3.4 M sodium chloride in
uremic patients produced an increase in plasma ADH parallel to
that in plasma osmolality (0.18 pg/nil per 1 mOsnt/kg). These re-
sults allow the relationship (threshold and sensitivity) between
plasma ADH and volemia to be estimated. They also show that
All at its physiologic plasma levels is necessary to obtain a full
ADH response to hypovolemia and that the effects of hypovo-
lemia are inhibited by a simultaneous decrease in plasma Os-
molality.
Acute renal failure following contrast media administration. B.
Canaud, B. Branger, R. Oules, A. Mimran, and C. Mion. De-
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partment of Nephrology, IVimes, France. The occurrence of
acute renal failure (ARF) following IVP (N = 6)and aortography(N = 4) using methylglucamine diatrizoate (MGD) was studied in
10 patients (age range, 52 to 78 yr). Before contrast media admin-
istration, chronic renal failure was present in 7/10 (serum creati-
nine, 1.9 to 7.8 mg/dl), diabetes in 6, severe atherosclerosis in 2,
nonsecreting multiple myeloma with hypercalcemia (14 mg/dl) in
1. Finally, a significant ECF depletion (A body wt, 6%) was pres-
ent in 4 patients. Oligoanuria occurred in all subjects with 24
hours after MGD. In fact, ARF presented as either a transient
oliguria when recognized early (6/10) or severe ARF when diag-
nosed late (4/10). Renal function returned to control level within
8 to 28 days in 7 patients; 3 patients died. The mechanisms of this
type of ARF are unclear; however, myoglobulinuna occurred in
2 patients, 1 patient was treated by Captopril, and 6/10 were on
chronic diuretic therapy before the administration of MGD. Four
renal biopsies were done, osmotic nephrosis was present in one.
In conclusion, ARF following contrast media may be severe and
lethal; this investigation must be avoided in high-risk patients,
mainly in those subjected volume depletion.
Treatment of IgA nephropathies with plasma exchanges alone.
J. M. Chalopin, G. Rifle, Y. Tanter, J. F. Cabanne, and E. Jus-
trabo. Unite de Néphrologie, Hôpital du Bocage, D(jon,
France. Two cases of IgA nephropathy associated with an in-
crease in the serum IgA level have been treated by plasma ex-
changes (EP) only. The first case deals with a 7-year-old girl hav-
ing a focal and segmental proliferative Henoch-SchOnlein (HS)
glomerulonephritis with 30% of epithelial crescents. There was a
nephrotic syndrome and normal renal function. The IgA level
increased to 3.4 g/Iiter (normal value (NV): 1.2 0.5 g/liter). The
second observation is of a 64-year-old man having a membrano-
proliferative glomerulonephntis associated with alcoholic liver
cirrhosis. There is a severe nephrotic syndrome and an increase
in the serum creatinine level at 310 molIliter. The IgA level was
7.4 g/liter (NV: 2.7 1.8 g/liter). The effectiveness of the therapy
was evaluated from the drop in IgA level below its average value
during the treatment. Eleven EP were made in the first patient in
a 3-week period, 28 were made in the second patient in a 2-month
period. Clinical symptoms disappeared in both at the end of EP.
Renal biopsy samples demonstrated IgA mesangial deposits in
the first case and rare deposits in the second. 14 and 6 months
later, respectively, clinical and anatomical results persist, al-
though the IgA level temporary increased after the EP were
stopped in the first case and has returned to its previous value in
the second case. Moreover, there remain only scars of fibrous
crescents in the girl having HS, whereas there is not any clear
modification in the second patient. These first morphologic and
clinical results obviously need additional studies. However, it is
interesting to underline the fast disappearance of the mesangial
IgA, which is very unusual in the course of HS nephropathy even
after corticoid treatment and/or immunosuppressive drugs. The
mechanism of action remains unclear: decrease in inflammatory
factors, passive decrease in normal or abnormal serum IgA,
polymenzed or in the form of immune complexes, recovery of
the functional capacity of reticuloendothelial system?
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Correlations between 99mTc DTPA clearance, 99mTc DMSA
fixation, and creatinine clearance. D. Chevet, P. le Pogamp,
J. J. Lejeune, A. Moisan, and J. Y. Herry. Nephrologie et
Médecine Nucléaire, C.H.U. Rennes, France. 60 patients, 14 to
72 years old, hospitalized for chronic renal disease, were studied
prospectively. Sequential gamma camera images obtained over a
30-nun period after i.v. injection of 10 to 15 mCi of 99mTc DTPA
were processed by a Cine 200 computer. Separate clearances
were calculated from the ascending slopes of the uptake curves
of the kidney scans. The global clearance of 99mTc DTPA was
determined from plasma values using Sapirstein bicompartimen-
tal model. Six hours after injection of 2 to 4 mCi of 99mTc
DMSA, a kidney scan was recorded on the computer. The per-
centage of fixation for each kidney was measured using a stan-
dardized model. Twenty-four-hour urine collections were used
to calculate creatinine clearance (Cr). Identical studies were
carried out on a group of 30 volunteers with normal creatinine
clearance values (120 28 mI/mm). The reference values (+2 SD)
for the global clearance of 99mTc DTPA are: 127 24 mI/mm.
The clearance for the right kidney is 63 15 and 64 14 mI/mm
for the left. The global fixation percentage for 99m DMSA was
40.2 7.8% with 20.2 4.8% and 19.9 4.8% for the right and
the left kidney, respectively. The DTPA global clearance values
and the DMSA fixation percentage (DTPA/DMSA) were corre-
lated both among themselves and separately with Cc. for the en-
tire group studied (N 90). The respective correlation coeffi-
cients were 0.89, 0.90, and 0.88. Identical correlations DTPAI
DMSA were obtained for separate functions of the right and left
kidney: 0.87 and 0.87. So far these technetium renal tracers have
not been correlated with the Ccr for a large sample of subjects;
neither have they been compared among themselves nor be-
tween individual kidneys. Our results show that DTPA and
DMSA (indirectly) give an equivalent measurement of GFR. Mor-
phologically, DMSA is more discriminating, but DTPA gives a
more precise estimation of cortical perfusion than does DMSA.
In four instances, DTPA demonstrated the presence of a kidney
that was not detected by IVP or DMSA.
Nephrotoxicity of gentamicin in the human kidney. M. E. de
Broe, G. A. Verpooten, R. Rutsaert, U. Paulus, F. Van Hoof, P.
Tuickens, and P. Zachee. Department of Nephrology-Hyper-
tension and Pathology, University of Antwerp; and In.ctitute of
Cellular and Molecular Pathology, Université Catholique de
Louvain, Belgium. It is now well established that amino-
glycosides accumulate in the renal cortex of animals and man. In
animals, the uptake of part of the filtered drug by the proximal
tubule through binding to brush border membranes and pino-
cytosis induces a lysosomal phospholipidosis. Two females, 68
and 55 years old, with normal renal function at admission devel-
oped acute renal failure during gentamicin treatment (80 mg
twice a day i.m., for 25 and 28 days). The gentamicin concentra-
tions in serum, urine, and renal tissue (biopsy specimen of 9.5
and 3.3 mg) were as follows:
Serum Urine Renal tissue
Patient 1 7.0 g/ml 16 ig/ml 205 g/g
Patient2 l.2g/ml 2 .7g/ml ll6sg/g
Light microscopy showed extensive tubular lesions and "mye-
bid bodies" in the EM. The sphingomyelinase activity of both
cortex fragments was reduced to 50 and 33% of normal value.
The present data are compatible with previous observations on
cultured cells (confirmed with rat kidney) that showed gen-
tamicin toxicity to be associated with a decrease of phospholi-
pase activity inducing lysosomal phospholipidosis.
Tissue culture of rat glomerular endothelial cells. J. B. Foidart,
C. Dechenne, C. H. Dubois, and P. R. Mahieu. Department of
Medicine, State University of Liege, Belgium. The renal glomer-
ulus contains at least, three cell types: epithelial, mesangial, and
endothelial cells. Reliable growths of glomerular cells in vitro
have allowed the characterization of two major cell types: epi-
thelial and smooth muscle-like (mesangial) cells. In the present
work, a method allowing the selective culture of rat glomerular
endothelial cells is described. Glomeruli were isolated from rat
kidney cortex by collagenase digestion, sieving, and differential
centrifugations. They were incubated for 5 mm in distilled water
at 37° C. By transmission electron microscopy, it was found that
these glomeruli contained mesangial and endothelial cells only.
The epithelial cell-free glomeruli were cultured in a conditioned
medium containing insulin. Using 3H-thymidine, one peak of cell
division occurred after 7 days of culture, reaching its maximum
on day 22. Two cell types were observed: (1) the first cell type
did not contain the antiheniophilic factor antigen and did not ex-
hibit any C3 or Fc binding sites; these cells, howeyer, exhibited a
contractile activity in presence of angiotensin II, were injured by
very low concentrations of mitomycin C (10 g/ml for 24 hours),
and contained large bundles of microfilaments similar to those
observed in cultured smooth muscle cells; (2) the second cell
type did not present any C3 binding activity; these cells did not
contract in response to angiotensin II, but exhibited Fc binding
sites, contained the antihemophilic factor antigen (as cultured
endothelial cells), and were resistant to mitomycin C. This last
treatment further allowed the selective culture of glomerular
endothelial cells. The data demonstrate that endothelial cells can
be isolated and cultivated from normal rat glomeruli.
Anti-type IV procollagen and antilaminin antibodies in Good-
pasture's syndrome. J. B. Foidart, Y. Pirard, J. M. Foidart, C.
H. Dubois, and P. Mahieu. Department of Medicine, State Uni-
versity of Liege, Liege, Belgium. Antigbomerular basement
membrane (GBM) antibodies play an important role in the patho-
genesis of Goodpasture's syndrome (GS), although the chemical
nature of the GBM antigen(s) responsible for this autoimmuniza-
lion remains a matter of controversy. The failure to unequivocal-
ly identify the antigen(s) involved in GS results from difficulties
in obtaining authentic basement membrane subunits, and also in
obtaining a large number of serum samples from patients pres-
enting with this syndrome. The sera of 19 patients presenting
with a GS and the sera of 30 normal blood donors were tested by
radioimmunoassay, using a GBM antigen containing the disac-
charide and the heteropolysaccharide chains of the starting
membrane material, and two major basement membrane sub-
units: the type IV procollagen and a noncollagenous glycoprotein
(laminin) purified from the basement membrane matrix secreted
by a murine tumor. Separation of free radioactive antigens from
those bound to immunoglobulins was obtained either by precipi-
tation with polyethylene glycol or by coprecipitation. In marked
contrast to the normal sera, the sera from 15 out of 19 patients
with a GS exhibited high levels of anti-GBM, anti-type IV pro-
collagen, and antilaminin antibodies. The other 4 sera samples
did not react with the three basement membrane antigens. The
antibody titers and their avidity for the basement membrane anti-
gens, however, varied according to the interval from the onset of
the disease, the antigens used, and the sera tested. Kidney
eluates from 3 positive" patients contained variable amounts of
the three antibodies. The data demonstrate that both basement
membrane subunits may be responsible for the autoimmuniza-
tion appearing in GS. This suggests a polycbonal rather than a
monoclonal stimulation in this disease.
Changes of pure pancreatic secretion in patients with chronic
renal failure treated by hemodialysis. R. Frayssinet, S. Saingra,
A. Murisasco, L. Multigner, J. Sahel, and H. Sarles. Service de
Néphrologie, Hópital Ste Marguerite, Marseille, and Unite de
Recherche de Pathologie Digestive, INSERM U. 31 Marseille,
France. In 20 patients suffering from chronic renal failure treated
by hemodialysis (CRFH), we studied the pure pancreatic juice
(PPJ) collected by endoscopic cannulation of the papilla. None of
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the CRFH patients presented with either a clinical history or up-
per gastrointestinal radiographic changes typical of chronic cal-
cifying pancreatitis (CCP). The results observed in patients were
compared to those of ten subjects free of any organic disease
(controls: C). PPJ was collected during 20 mm in 1-mm samples.
Secretin GIH (0.5 U/kg1) and pancreozymin GIH (3 U/kg')
were given as boluses to control and CRFH patients, respective-
ly, at the beginning and at 10 mm into the test. Collection was
complete (20 samples) in 14 CRFH patients. The volume of PPJ
was significantly greater in CRFH than it was in C, with the ex-
ception of the first sample. Bicarbonate concentrations and pro-
tein concentrations were not significantly modified, whereas out-
puts were increased without reaching statistical significance.
Lactoferrin level (LF) was more than 0.05% of total proteins in 4
CRFH (20%). In normal subjects, LF levels range from 0 to
0.03% of total proteins; higher values are observed only in 5% of
the normal population. The increase in volume of PPJ could be
due to an increase of the release of secretin, to a decrease of its
catabolism, or to an increase of the sensitivity of the CRFH pan-
creas to this hormone. Abnormally high levels of LF are ob-
served specifically in patients suffering from CCP, whatever the
stage of the disease. It can be speculated that the high rate of LF
found in 20% of CRFH could be related to either the presence of
CCP prior to the clinical expression, or a metabolic anomaly
("uremic pancreas"). Our results are consistent with recent ob-
servations showing that, on one hand, LF inhibits the in Vitro
granulopoiesis, and, on the other hand, that the sera of patients
with chronic renal failure contain a factor responsible for such an
inhibition.
Systematic angiographic investigation of vascular access in
chronic hemodialysis. J. Holvoet, M. Christiaens, R. Van Hee,
A. de Schepper, M. E. de Broe. Departments of Nephrology,
Surgery, Radiology, University of Antwerp, Aniwerpen, Bel-
gium. The vascular access of patients with chronic hemodialysis
was systematically investigated by direct puncture of the afferent
artery, or by venous fistulography when dysfunction was ob-
served during dialysis. Fifty-eight examinations were performed
in 46 patients (22 to 76 years of age, 2 to 45 months of dialysis,
mean, 23 months) during a 12-month period. Vascular access in-
cluded Scribner shunts (9), Cimino fistulas (49), Thomas shunts
(3), vena saphena grafts (11), bovine grafts (4), and impra grafts
(2). The following abnormalities were found: calcification (1), ar-
terial stenosis (3), arterial thrombosis (6), arterial aneurysm (2),
venous stenosis (4), venous thrombosis (11), venous aneurysm
(4), collateral circulation (8), venous pseudoaneurysm (2), de-
layed emptying of the venous bed (4), hematoma (2), and shunt
stenosis (3). Of 37 clinically normal fistulas, 10 (27%) presented
abnormalities including thrombosis of the arterial or venous limb
of the fistula. Angiography of the vascular access seems to be a
simple, harmless examination and highly informative for plan-
fling surgical correction of the AV fistula. We presently have the
following policy: evaluation of the AV fistula soon after surgical
construction and reexamination every 12 months if no problem
arises, and immediate angiography if blood flow problems arise
during dialysis.
Kinetics of plasma and urine aluminum concentrations after kid-
ney transplantation: Clinical and EEG correlations. M. Hour-
mant, J. P. Soulillou, M. F. Vecchierini, H. L. Boiteau, C. Me-
tayer, and J. Guenel. Service de Néphrologie, Laboratoire de
Physiologic, Centre de dosage des éléments traces, CHU
Nantes, France. Kinetics of plasma and urine aluminum concen-
trations, with parallel clinical and EEG monitoring, were studied
in 22 kidney recipients including 2 dialysis encephalopathic (DE)
and 20 nonencephalopathic patients, during 3 months following
grafting. Three groups of patients are defined according to graft
function outcome: group I, success immediate (Ia) or delayed
(Ib); group II, immediate and definitive failure; and group III,
hemodialyzed patients undergoing nontransplantation surgery.
Group Ta recipients, including the 2 encephalopathic patients,
eliminated high amounts of aluminum and progressively normal-
ized their plasma aluminum concentrations within 6 months after
grafting. In group lb. the plasma aluminum concentrations fell
back close to baseline, but after a period they rose significantly
(P < 0.01), which occurred as well in group II, though to a lesser
extent. In the 2 cases typical of DE, EEG DE-related abnormal-
ities completely disappeared within 3 months. Non-DE-specific
tracings remained unchanged in all groups. These data also sug-
gest that early preclonic symptoms of DE are reversible after a
successful transplantation, but when graft function is delayed, a
high increase in aluminum plasma concentrations occurs, raising
the question of its possible relevance to a worsening of encepha-
lopathy.
Cystine crystalluria and urinary relative saturation in cystine
stone formers. M. Labeeuw, N. Pozet, P. Zech, C. Gerbaulet,
andf. Traeger. Clinic of Nephrology, E. Herriot Hospital, Lyon,
France. The current theory of lithogenesis considers spontane-
ous crystallization to be the first step of stone formation. Crystal-
lization depends on urinary saturation. This theory was checked
in cystine stone formers (CSF) by simultaneous measurement of
cystine crystalluria and urinary relative saturation (RS). Cystine
crystals were found in 83% of urinary samples from CSF and
never in the 400 samples from controls (C). Urinary RS for cys-
tine was significantly higher in CSF (0.81 0.23, N = 21) than it
was in C (—3.1 1.29, N = 51, P < 0.01). Crystals were never
found in undersaturated urine but were always present when RS
was above 1. Thus, the presence of a cystine crystalluria is still a
good clue to the diagnosis of cystinuria. Crystalluria is correlated
with RS, indicating that the theory developed for calcium oxalate
stones is valid for cystine stone formers, without a need for a
defective inhibitor. The study underlines the limits of hydration
and alkalinization in the management of cystine lithiasis.
Fasting urinary calcium/creatinine ratio: Normal values and
findings in 379 calcium stone formers. M. Laheeuw, N. Pozet, P.
Zech, C. Gerbaulet, and J. Traeger. Clinic of Nephrology, E.
Herriot Hospital, Lyon, France. Fasting urinary calcium/creati-
nine ratio (CalCreat) is an important parameter in evaluating cal-
cium stone formers (CSF) with hypercalciuria. Normal values
were determined in 317 controls (C): 57 were normal volunteers,
and 260 were patients with no known calcium disturbance but
various GFRs. CalCreat (mM/liter) is correlated with GFR and
NalCreat (r = 0.7) but is unrelated to age and sex except for
females above 50 years. CSF (N = 379) exhibited significantly
elevated Ca/Creat, still correlated with Na/Creat (r = 0.57). So-
dium restriction (S—) decreased Ca/Creat to values found in C
under normal sodium diet(S+): CSFS+, 0.459 0.338; CSFS—,
0.231 0.194; CS+, 0.237 0.110; CS—, 0.158 0.09. Among
235 CSFS+ with GFR above 60 mllmn, 88 exhibited elevated Ca/
Creat (primary hyperparathyroidism: 21.5%; normocalcemic hy-
percalciuria, HC: 57%). In 80% HC selected at random, Ca/Creat
was normal in 43.5% of cases. This study establishes the normal
values of Ca/Creat for various GFR and sodium contents in the
diet and determines its diagnostic significance. The relatively low
frequency of normal CalCreat in HC suggests either that the real
frequency of absorptive HCA is lower than expected or that
HCA cannot readily be separated from renal HC using this
simple test.
Hyperparathyroidism and red cell production. B. Lacour,
C. Basile, and T. Drüeke. INSERM U.90, Clinique Néphro-
togique Hop. Necker, Paris, France. We previously sug-
gested that parathyroid hormone could play a role in the patho-
genesis of the anemia in chronic renal failure. To further investi-
gate this question, we studied the influence of two experimental
models of hyperparathyroidism on red cell production in the rat.
The rate of red cell production was evaluated using the technique
of RBC 59Fe incorporation at 24, 48, and 120 hours after the iv.
administration of the isotope. Furthermore, the number of circu-
lating reticulocytes was determined under the same conditions.
138 Abstracts
In the first study, 8 normal rats and 8 rats with hyper-
parathyroidism (HPTH) secondary to a calcium-poor diet were
investig/ited. In a second study, 6 rats received exogenous para-
thyroid extract (PTE) and were compared with 6 control rats.
The 59Fè incorporation into red cells was significantly lower in
HPTH cats than it was in control animals. These results were
obtained in basal conditions as well as after bone marrow stimu-
lation by hemorrhage. Under both conditions, the number of cir-
culating reticulocytes was significantly reduced in HPTH when
compared to control rats. A similar inhibitory effect on RBC pro-
ductionnd reticulocyte count was observed after PTE adminis-
tration Conclusion. Hyperparathyroidism is associated with a
decreaé in RBC production in the rat. The severity of anemia in
chronic uremic patients could be at least partially due to a con-
comitant excess of parathyroid hormone secretion.
Clofibrate pharmacokinetics in nephrotic syndrome. S. di
Giulio, LB. Lacour, T. Drdeke, A. Nicolal, R. Boa/u, and J. L.
Funck-Brentano. Hôpital Necker, Paris, France. Clofibrate
treatment of patients with nephrotic syndrome (NS) including
hyperlipidemia has been suggested to prevent vascular damage.
However, regular clofibrate administration may be hazardous
because of decreased protein binding in NS. The present study
has been designed to determine, in NS patients, the pharma-
cokinetics of CPIB (chiorophenoxy-isobutyrate, the main active
metabolite of clofibrate) using gas liquid chromatography. Six
healthy volunteers and seven patients with NS and normal renal
function (serum creatinine, <110 mol/liter) received a single or-
al dose of clofibrate (25 mg/kg body wt). Twenty-four-hour blood
and urine samples were collected for the measurement of CPIB.
Moreover, in vitro CPIB binding was determined using the equi-
librium dialysis method. The unbound CPIB fraction was mea-
sured on individual plasma samples from control subjects and
NS patients; further measurements were performed after sepa-
rate pooling of plasma samples from each group. Mean CPIB
peak plasma concentration was observed for both groups ap-
proximately 4 hours after oral administration: 57.8 (sEM) 7.2
g/ml or NS vs. 105.8 10 g/m1 for control subjects (P <
0.02). Mean CPIB plasma t '/ is 10 hours in NS and 17 hours in
control subjects (P < 0.05). Distribution volume is 0.31 0.02
liters/kg body wt in NS vs. 0.23 0.02 liters/kg body wt in con-
trols (P < 0.05). The in vitro study shows that an inverse relation
exists between plasma albumin concentration and the unbound
plasma CPIB fraction. However, the unbound plasma CPIB frac-
tion of NS remains higher than that of control plasma even when
compared at identical albumin concentration. Conclusion. Clofi-
brate plasma half-life is decreased in NS patients without renal
failure. In those patients, oral administration has to be adapted to
the increased amount of unbound clofibrate in a distribution vol-
ume larger than normal.
Longterm evolution of membranoproliferative glomerulone-
phritis treated with nonsteroidal antiinflammatory agents. G.
Lagrue, D. Belghiti, G. Hirbec, and A. Sobel. C.H.U. Henri
Mondor, Creteil, France. Actuarial survival curves have estab-
lished the severe spontaneous outcome of MPGN. For 12 years
(1967 to 1978), 50 patients with MPGN type I (subendothelial
deposits) were treated with various nonsteroidal anti-
inflammatory agents (NSAI), including indometacin, ketoprofen,
niflumic acid, flurbiprofen, and diclofenac. At the initial evalua-
tion, only 6 patients had a moderate chronic renal failure (CRF)
with serum creatinine ranging between 1.5 and 2.0 mg/dl. In the
group of patients with normal renal function, all tested drugs had
a comparable effect: disappearance of proteinuria in 17 cases,
reduction of proteinuria (<2 glday) in 20 cases, no effect in 7
cases. Modifications of proteinuria were drug-dependent since: a
precise therapeutic dose was always required, all modifications
were reversed when therapy was interrupted, were again ob-
served when the antiinflammatory treatment was resumed, com-
parisons of proteinuria levels (in g/day) between periods with and
periods without NSAI showed a significant decrease of protein-
uria. Side effects were always moderate, and drug-dependent
acute renal failure was never observed. This therapy was less
effective in patients with moderate CRF (reduction of proteinuna
in 3 cases out of 6). To establish the long-term effect of this thera-
peutic regime (>6 years in most cases), we studied the following
criteria: (1) actuarial curves showed a clear improvement when
compared to the data previously published by other groups. This
concerned both renal survival and the time of evolution with nor-
mal renal function. (2) kidney biopsies were performed in 14 pa-
tients receiving effective NSA! drugs for more than 6 years. In 3
cases, all histologic abnormalities had disappeared. In 7 other
cases, a considerable improvement was observed concerning cell
proliferation, capillary wall thickening, as well as intensity of im-
mune deposits. These results were mainly observed in patients
with disappearance of proteinuna during NSA! administration.
Effect of renal vasodilators on papillary hemodynamics and so-
dium excretion in the rat. N. Lameire, M. Schurgers, R. Van-
holder, and S. Ringoir. Renal Division, University Hospital, De
Pintelaan, Gent, Belgium. In contrast with most renal vasodila-
tors, such as acetylcholine (ACh), secretin increases renal blood
flow in the dog without a marked effect on sodium excretion
(UNaV). To investigate this observation, we studied in rats the
relationship between renal vasodilatation, UN,V, and papillary
plasma flow (PPF), by infusing them either with ACh or secretin
into the aorta at the level of both renal arteries. ACh significantly
increased GFR, PAH clearance, and UNV by +0.35 mI/mm,
+2.11 ml/min, and + 1.77 tEq/min, respectively; P < 0.05. PPF
rose from 50 2.6 mI/mm per 100 gin control rats to 91 4.7 ml/
mm per 100 g after ACh (P < 0.001). Despite a similar increase in
PAH clearance after secretin (+2.21 mI/mm; P < 0.01), UNV
remained unchanged and PPF was only slightly, although signifi-
cantly, increased (from 50 2.6 to 65 2.75 mI/mm per 100 g; P
< 0.05). Both total kidney and papillary vasodilation, and the
increase in UNaV after ACh, were blocked by previous adminis-
tration of meclofenamate (M), a prostaglandin inhibitor. No ef-
fect of M in secretin-infused rats was observed. Conclusion. (1)
The relationship between total renal vasodilatation and natnur-
esis was dissociated with secretin, but not with ACh. However, a
relationship between the natnuresis and the effect on papillary
hemodynamics was observed with both vasodilators. (2) The
renal hemodynamic and natnuretic effects of acetylcholine are
probably mediated by prostaglandin release.
Circulating immune complex detection in human glomerulone-
phritis by the PEG-EDTA technique. B. Laurent-Pilon-
chery, J. C. Sabatier, C. Genin, R. Gonthier, and F. C. Ber-
thoux. Service de Néphrologie Hópilal de Bellevue, Saint-
Etienne, France. In a prospective study, we screened sera sam-
ples of 128 patients with glomerulonephritis (GN) for the pres-
ence of circulating-immune-complex- (CIC) fixing Clq by precipi-
tation of native Clq with 2% polyethylene glycol (PEG) in the
presence of 10 mri EDTA. The amount of precipitated Clq, as
measured by Mancini, is less than 27% (±2 SD) of the original
value in control sera. We found 35/128 (27%) positive samples,
distributed as follows: 4/17 (24%) in acute GN, 10/15 (67%) in
vasculitis (13 lupus, 1 periarteritis nodosa, I Wegener), 2/16
(13%) in membranous GN, 13/24(54%) in membranoproliferative
GN, 3/16 (19%) in segmental focal hyalinosis, 2/10(20%) in mini-
mal lesions nephrotic syndrome, and 1/30 (3%) in mesangial IgA
GN. We then correlated these results with clinical, serologic,
and pathologic data. Whatever the type of GN, the presence of
CIC-fixing Clq correlated significantly well with: the presence of
chronic renal failure (serum creatinine, >2 mg/dl) 2 = 5.48;P <
0.02), the presence of hypocomplementemia (x2 12.30; P <
0.001) the presence of low serum C3 (x2 = 8.25; P < 0.01), the
activation of C3 through normal pathway (low serum C4 and/or
Clq) (f = 18.12; P < 0.001), and the presence of glomerular
deposits of C3 (x2 = 8.52; P <0.01), of C4 (x2 = 7.10; P <0.01),
and of Clq (x2 = 4.11; P < 0.05). The technique is simple, does
not require labeled Clq, and allows the further study of antigenic
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or antibody determinants of the complexes. Its sensitivity is near
that of the '251-Clq binding assay technique. Such routine screen-
ing is a major immunopathologic step in the investigation of hu-
man GN.
Analysis of hypercalciuria by an ambulatory test. A. Meyrier,
A. J. Seiler, F. Paillard, and K. S. Ang. Service de Nephrologie,
Hôpital Tenon, Paris, France. Thirty-eight patients with neph-
rolithiasis due to hypercalciuria (HC) (24-hours Uca  0.1
mmoles/kg) were investigated by an ambulatory test derived
from the protocol described by C.Y.C. Pak. After a 12-hour fast,
urine was collected for 2 hours (UA); an oral calcium load of 1000
mg was administered with a standard breakfast, and urine was
collected for the next 4 hours (U5), UA and UB were analyzed for
calcium-creatinine and for cAMP clearances. Serum calcium,
phosphate, and cAMP concentrations were also measured before
and after the calcium load. The normal upper limits for calcium!
creatinine are: UA  33, U  47 mmoles. Results. Three groups
can be distinguished. Group 1: Absorptive HC (22 cases, 58%):S, = 2.302 0.11, S, = 1.05 0.16 mmoles/liter. UA (N = 22)
CalCreat = 0.214 0.0743, UB (N = 22) CalCreat = 0.829
0.253 (P <0.001), UA (N 17) CCAMP = 179 58 mI/mn, UB (N =
17) CCAMP = 157 90 (NS). Group 2: Tubular HC (12 cases,
32%): Sca = 2.34 0.081, Spj = 1.14 0.14. UA (N = 12) Cal
Creat = 0.486 0.130, U5 (N = 12)CalCreat = 1.213 0.423 (P
< 0.001). UA (N = 10) CCAMP = 209 86, U5 (N = 10) CCAMP =
133 57 (P < 0.001). Group 3: Parathyroid adenomas (4 cases,
10%): Sc = 2.94 0.39, S. = 0.75 0.05. UA (N = 4) Ca/Creat
= 0.673 0.455, U5 (N = 4) CalCreat = 1.258 0.528 (P <
0.01). UA (N = 4)CCAMP = 207 135. UB (N = 4) CCAMP = 183
112 (NS). Conclusions. (1) This ambulatory test allows the dis-
tinction between absorptive, tubular, and resorptive HC. (2)
CAMP,, is high and nonsuppressible in absorptive HC, high and
suppressible in tubular HC, and high and nonsuppressible in
parathyroid adenomas. (3) The population of absorptive HC is
not homogeneous. It is in this group that perhaps some cases of
normocalcemic parathyroid adenomas should be found.
Combined hemoperfusion-hemodialysis in organic phosphate
poisoning. J. Nagler, R. A. Braeckman, J. L. Willems, M. E. De
Broe. Department of Intensive Care, Algemeen Ziekenhuis Mid-
delheim, Department of Nephrology, University of Antwerpen,
Heymans Instituut, University of Gent, Belgium. Despite con-
ventional therapy, poisoning with organophosphates remains
highly lethal. Dimethoate and other organophosphates can be
cleared from the blood by hemoperfusion and hemodialysis in
experimental conditions. We report a patient treated with com-
bined prolonged hemoperfusion (HP, Adsorba 300c, Gambro,
Sweden) and hemodialysis (HD, C-Dack 1.3 Cordis Dow, USA)
for severe dimethoate poisoning. This procedure was adopted
since the combination of dialysis and adsorption may improve
overall drug removal. Moreover, the artificial kidney allows cor-
rection of hypothermia, fluid imbalance, and adjustment of
serum electrolytes. Finally, the prolonged use of HP-HD should
prevent rebound phenomena. Combined HP-HD was performed
during 24 hours using the same charcoal column and dialyzer.
Adequate anticoagulation was obtained by monitoring the whole-
blood-activated partial tromboplastin time. The patient (a 34.
year-old female) ingested 10 g of dimethoate (Teletox 10) in a
suicide attempt, 0.5 hours before admission to the hospital. On
admission, the serum concentration of dimethoate (analyzed by
gas chromatography) was 2340 ng!ml. She received conventional
treatment and combined HP-HD was started within 2 hours after
admission. At the start, the serum level had risen to 3110 ng!ml,
declined constantly during the epuration, and after 18 hours of
this procedure no more dimethoate could be detected in the
serum. During those 18 hours, 52.09 mg of dimethoate entered
the epuration system via the plasma, 24.59 mg were extracted by
the charcoal column, and 11.92 mg by the hemodialysis. Further
well-documented studies are needed to assess the value of this
HP-HD treatment in acute organophosphate poisoning.
Resolution of malignant hypertension and acute renal failure in
scleroderma: Case report. K. Rebaiz, P. Birembaut, J. Petit, C.
Wolf, and M. Legrain. Service de Nephrologie-Hemodialyse.
Hôpital Manchester, Charleville Mézières, and Laboratoire Pol
Bovin, C.H.U. Reims, France. Renal failure is a common cause of
death in patients with systemic sclerosis (diffuse scleroderma). The
poor prognosis is due to malignant hypertension and rapid deteri-
oration of renal function. Therefore, bilateral nephrectomy fol-
lowed by hemodialysis and transplantation are proposed to avoid
fatal outcome. We describe the case of a 37-year-old male suf-
fering from diffuse scleroderma who developed malignant hyper-
tension and acute renal failure. The renal biopsy and biologic
investigations evidenced a thrombotic microangiopathy. The
plasma renin activity was in a very high range. Control of hyper-
tension and improvement of renal function were obtained by
intensive management of hypertension with i.m. clonidine,
propranolol, and dihydralazine. Ten months later, plasma creati-
nine is 2 mg/dl, and blood pressure is 140/80 mm Hg. This case
and similar ones reviewed in the literature demonstrate that bilat-
eral nephrectomy should be performed in scleroderma renal
crisis" only after failure of aggressive antihypertensive therapy.
Renal pelvic stones composed of glafenic acid in two patients
under prolonged treatment with analgesics. R. J. Réveillaud, M.
Daudon, M. F. Protat, R. Rymer, E. Amar, andJ. Pottier. Serv-
ice de Médecine Interne el Nephrologie, and Laboratoire Cris-
tal, C. H. Saint-Cloud, France. A 69-year-old woman had been
taking analgesics for 3 years, for sequelas of discal hernia that
had been operated on. She then underwent two painful abdomi-
nal atypic attacks at 10-month intervals. An abdominal echo-
tomography revealed hydronephrosis with pelvic lithiasis, con-
firmed by IVP which showed 6 small slightly radioopaque stones.
A pyelotomy resulted in extraction of brown stones, presenting
cristalline surface and yellow, soft, and amorphous section.
They consisted of 50% calcium oxalate, 33% glafenic acid, and
10% proteins. A 64-year-old woman, suffering from hyper-
tension, anxiety, and arthrosis, has been taking analgesics for 4
years. Three febrile urinary infections during the third year were
not explored. Six months later, a new infection occurred. A mod-
erate renal insufficiency with hypertension and polycythemia
was then discovered. 1.V.P. showed an important round and ra-
diotransparent defect in the renal pelvis, as in uric lithiasis. A 6-
week urine alkalinization was ineffective. Pyelotomy resulted in
extraction of a big, soft, and greenish stone, presenting a yellow
and amorphous section, with no calcium, but with 75% glafenic
acid and 25% proteins. Glafenic acid was identified by JR spec-
trography; the unusual spectrum was compared with that of the
glafenine one, which had been previously studied in a patient
with an acute voluntary poisoning with this drug. Through this
method, the glafenine metabolites found in the stones represent
33% in our first case and 75% in our second case. Through other
methods, as UV spectrophotometry and chromatography, 26%
and 61%, respectively, are found. The metabolites are the glafen-
ic acid and the hydroxyglafenic acid, in a proportion of 9 to 1,
identical in both cases. This proportion is consistent with that
found in the urine of a normal subject after administration of an
usual therapeutic dose of this drug, as far as the whole of the free
and conjugated metabolites is considered.
Peculiar association of a membranous glomerulonephritis with
interstitial infiltration by lipophages, nodular regenerative hyper-
plasia of the liver, and mixed cryoglobulinemia. P. Ronco, L.
Morel-Maroger, R. Poupon, P. Prud'homme de Saint Maur, P.
Verroust, and F. Mignon. Service de Nephro/ogie and Unite 64
INSERM, Hôpital Tenon, Paris, France. A 20-year-old woman
was first seen in 1971 because of proteinuria and minimal micro-
scopic hematuria, without nephrotic syndrome, hypertension, or
renal failure. The biopsy showed a severe atypical membranous
glomerulonephritis with extensive capillary wall lesions and dif-
fuse granular deposits of lgG, C3, and 1gM. Immunologic data
showed a mixed IgM-IgG cryoglobulinemia and a low level of
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CH50. Tests for systemic LE were repeatedly negative. Eight
years later, the patient was readmitted for ascites and enlarged
spleen without liver enlargement. The liver function tests were
within normal. Although clinical renal symptoms were identical
to those noted in 1971, renal lesions were much more severe with
two very unusual findings: intracapillary thrombi and massive
infiltration of the interstitium by foam cells. Portal venous hyper-
tension indicated needle liver biopsy, which showed nodular re-
generative hyperplasia. Search for the HBs antigen was nega-
tive. Cryoglobulinemia was again found. High C3d level in-
dicated complement activation. It should be stressed that during
these 8 years, she carried out three successful pregnancies, but
the first child suddenly died on the third day of life, and the third
child at 2 days of age developed a severe liver insufficiency,
which was poorly explained, but healed with symptomatic thera-
py. The association of a nodular regenerative hyperplasia of the
liver and glomerulonephritis has not been reported. Moreover,
the renal lesions are unusual. It is suggested that there is a causal
relationship between the membranous GN and the liver disease,
although the immunologic mechanisms are poorly understood.
Focal and segmental glomerulosclerosis and hypertension. A. J.
Seiler, A. Meyrier, P. Simon, L. Morel-Maroger, J. P. Méry,
and G. Richet. Hdpital Tenon, Paris, France. The prevalence,
date of onset, and in some cases the mechanism of hypertension
(HBP) were compared in two groups of patients (pts) with focal
and segmental hyalinosis (FSH), according to the presence or the
absence of the nephrotic syndrome (NS). Group I (with NS):
HBP was found in 20/60 pts (age, 36 {sD] 18 years). HBP was
present in only 6 pts (10%) from the very beginning of the NS.
Among these 6 cases (1) 2 pts were over 60 years of age and renal
biopsy disclosed nonspecific arteriolar lesions, (2) 2 pts were un-
der 45 years of age, and in one, HBP had preceded the NS, (3) 2
pts suffered from uncontrollable severe HBP with high PRA.
Renal angiography disclosed a postbiopsy renal arteriovenous
fistula in one (age 27), and a renal artery stenosis in the other (age
45). Both were submitted to vascular surgery, and BP returned to
nearly normal levels with low-dose antihypertensive therapy. In
the other 14 pts, HBP appeared late in the course of the nephrop-
athy, at a stage of chronic renal failure, and soon before hemo-
dialysis in 7 cases. Group II (without NS): HBP was in 25/55 pts
(45.5%). In this group, HBP was directly linked to the disease
itself and had an unfavorable prognosis. It was associated with
microscopic hematuria in 7 cases (mean age, 42 years). Hematuria
was absent in the 18 other pts (mean age, 50 years). Out of 25
pts, 11 evolved to end-stage renal failure. Conclusion. Early
HBP is an important discriminating element between FSH with
and without the NS. In the pts with NS, HBP is not a direct
consequence of the renal disease, except at the stage of terminal
renal failure. The causes of HBP are the same as they are in a
random population, including renovascular HBP, which should
be looked for systematically. In terms of nosology, FSH with
the NS seems to be an entity different from FSH without the
NS, even if the glomerular pathologic changes are the same in
the two groups.
Studies on the catabolism of the hydroxylsine-linked disaccha-
ride units of basement membranes and collagens: Isolation and
characterization of a new rat-kidney a-glucosidase of high specific-
ity. M. Sternberg and R. G. Spiro. Department of Biological
Chemistry and Medicine, Harvard Medical School, Elliott P.
Joslin Research Laboratory and Peter Brigham Hospital, Bos-
ton, Massachusetts, U.S.A. A new a-glucosidase highly specific
for glucosyl-galactosyl-hydroxylysine residues characteristic of
basement membranes and collagens has been found in rat kidney
cortex. This enzyme, which has been designated as a 2-0-cr-a-
glucopyranosyl-5-0-f3-o-galactopyranosylhydroxy-L-lysine glu-
cohydrolase has been purified 176-fold from kidney cortex by
ammonium sulphate fractionation, Sephadex G-l00 filtration,
and DEAE-cellulose chromatography. Its molecular weight as
determined by filtration on a calibrated Sephadex G-l00 column
was 70,000 daltons. The glucosidase had maximal activity be-
tween a pH of 4.4 and a pH of 4.7 and acted optimally with gluco-
sylgalactosylhydroxylysine as substrate (Km = 5.7 ms), yield-
ing galactosylhydroxylysine and glucose. N-acetylation of the
hydroxylsyl disaccharide protected it from enzymatic hydrolysis
and indicated that the specificity of the glucosidase was partly
dependent on the presence of an unsubstituted c-amino group.
The enzyme was inactive toward all 13-glucosides and other a-
glucosides tested with the exception of kojibiose, maltose, and
isomaltose, which were hydrolyzed to a small extent. The en-
zyme could bring about complete removal of glucose from pep-
tides, as well as basement membranes and collagens containing
the glucosylgalactosylhydroxylysine unit; but the rate of release
from these substrates was slower than from the hydroxylysine-
linked disaccharide itself and suggested that the glucosidase's
physiologic role may be expressed at a late stage in the catabolic
process. The enzyme had no discernible divalent cation require-
ments and was unaffected by the presence of EDTA. D-glucono-
lactone caused a 50% decrease in glucosidase activity at an inhib-
itor-to-substrate molar ratio of 0.24. Activity of the enzyme was
highest in the kidneys of neonatal rats (3 days old) and decreased
with age. A specific glycosidase which could cleave the 0-f3-u-
galactopyranosyihydroxylysine bond could not be detected in rat
kidney cortex, although an acid 3-galactosidase was found which
could slowly hydrolyze this linkage but only after N-acetylation
of the hydroxylysyl galactoside. The occurrence of an a-glucosi-
dase that can degrade glucosylgalactosyihydroxylysine and the
absence of a complementary hydrolase for galactosylhydroxyly-
sine may have an important influence on the composition of uri-
nary hydroxylysyl glycosides.
Renal function studies in an experimental model of papillary ne-
crosis in the rat. R. Vanholder, N. Lameire, W. Eeckhaut, and S.
Ringoir. Renal Division, University Hospital, Dc Pintelaan,
Gent, Belgium. Twenty-four hours after the iv. injection of bro-
moethylaminehydrobromide (BEA) in rats, a uniform necrosis of
the medulla and the juxtamedullary nephrons is observed. The
present study investigates the renal function and the papillary
hemodynamics in response to acute volume expansion (YE)
(12% of body wt) in this model. Renal function studies were per-
formed in hydropenic (H) and YE sham- or BEA-injected rats. In
H normal animals, a GFR of 1.97 0.14 mlmin', a urinary
osmolality (Uosm) of 1011 94.5 mOsmkg1 and a fractional so-
dium excretion (FENd) of 0.18 0.026% were obtained. In con-
trast, BEA-treated H animals showed a lower GFR (1.16 0.14
mlmin'), alower Uosm of 469 30.31 mOsmkg', and a higher
FENa (0.37 0.06%). After VE, a similar Uosm and FENa of 302
17.5 mOsmkg' vs. 301.9 22.5 mOsmkg and of 10.97
1.18% vs. 13.6 1.77% were obtained in sham and BEA rats,
respectively. The papillary plasma flow (PPF) was measured in
each of the experimental groups by the albumin accumulation
technique. The mean value in hydropenic normal animals was
50.65 2.12 m1 100 g'min and increased to 66.03 2.00 ml
100 g1min1 after volume expansion (P < 0.001). In BEA rats,
the PPF was 58.86 2.33 ml 100 g'min1 in hydropenia (P <
0.01 vs. control animals) and remained unchanged after YE.
Thus, during H, BEA-induced papillary necrosis results in a salt-
wasting state and a urinary concentrating defect. The histologic
lesions cannot be explained by a decreased PPF. After yE, no
disturbance in renal sodium excreting capacity is observed.
These results are not in conflict with the nephron heterogeneity
hypothesis, claiming that during YE a greater delivery of sodium
out of deep nephrons is partially counteracted by an increased
sodium reabsorption in the papillary collecting duct.
Sorbistin: A new non-nephrotoxic aminoside. G. Viotte, M. Go-
din, J. P. Morin, J. P. Bendirdjian, and J. P. Fillastre. Hôpital
de Bois Guillaume, Bois Guillaume, France. Sorbistin (SOR A1)
is a new aminoside with a similar spectrum activity as other
aminoglycosides, including activity against many amino-
glycoside-resistant organisms. We have studied the renal toler-
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ance of Sorbistin A1. Pathology, light and EM examination.
There is no modification of the kidney structure after 50 and 100
mglkg/day SOR A1 for 8 days in Fisher 344 and Wistar rats. Enzy-
matic studies. Sorbistin induced no alteration either of alanine
amino-peptidase or of N-acetyl-f3-D-glucosaminidase activities
on renal cortical slices. A decrease of a-D-galactosidase activity
with 100 mg/kg/day of SOR A1 and an inhibition of sphingomye-
linase activity with both 50 and 100 mg/kg/day were demon-
strated. Subcellular studies. No modification of lysosomal struc-
tural latency was observed with doses ranging from 5 to 100
mL' of standard lysosomal suspension. Likewise, respiratory ac-
tivity of isolated mitochondria was not altered by doses of SOR
A1 of 100 to 800 g mL' in the incubation medium. We com-
pared these results with those previously obtained in our labora-
tory for ten other aminoglycosides, which were all nephrotoxic.
Our observations led us to conclude that SOR A1 has likely a
very low order of toxicity. This molecule had only three amino-
groups: it thus appears that aminoglycoside effects on subcellular
elements may depend on the number of aminogroups of the
molecule.
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Scanning electron microscopy of the renal papilla in experimen-
tal analgesic nephropathy in the mouse. 1. M. Al-Ani and Julia
Fourman. Departments ofAnatomy and Mull idiscipline Labora-
tories, School of Medicine, University of Leeds, Leeds, Eng-
land. Analgesic nephropathy was induced in the mouse by ad-
ministration of aspirin in the drinking water, and the develop-
ment of changes in the form and surface of the papilla were
followed by scanning electron microscopy (SEM). The drinking
water of 21 young adult mice (each weighing 20 to 25 g) was
replaced by a saturated solution of aspirin made up freshly each
day. Three experimental mice and one control from the same
batch were killed 10, 15, 20, 25, 30, 35, and 40 weeks after the
start of treatment. The mice were anesthetized, and the kidneys
were fixed in situ with 3% buffered glutaraldehyde, removed, bi-
sected through the long axis, and after further fixation prepared
for SEM. The first detectable change in the form of the papillae
was a generalized swelling producing a thickened blunt appear-
ance, followed by shrinkage and longitudinal furrowing. Later,
there was necrosis, loss of the tip, and repair resulting in shorten-
ing and gross distortion. At 10 weeks, there were changes in the
surface epithelium, and a few cells at the tip appeared collapsed,
with a concave surface in place of the normal convexity. These
changes progressed in severity, and at 20 weeks crumpled cell
remnants formed ribbon-like bands surrounding islands of
healthy tissue. At 25 weeks, the openings of the ducts were dis-
torted by an overgrowth of large swollen cells. The papillary epi-
thelium receives its blood supply from vasa recta, and the pat-
tern of islands of healthy cells surrounded by dying cells is con-
sistent with reduced flow through the vasa recta, resulting in
ischemia of cells on the periphery of the area supplied. The col-
lecting duct epithelium probably receives some oxygen from the
urine, which would account for the hyperplasia of cells around
the openings. The denuded surface may be covered in the same
way after loss of the necrotic tip.
Sexual function in chronic renal failure: No benefit from zinc. A.
C. Brook, D. G. Johnston, M. J. Watson, D. B. Cook, M. K.
Ward, and D. N. S. Kerr. Welicome Research Laboratories,
Royal Victoria Infirmary, Newcastle upon Tyne, England. Sex-
ual function. In a cross-sectional study of 43 male patients with
chronic renal failure (9 treated conservatively, 22 dialyzed, 12
transplanted), sexual function was assessed by questionnaire.
Fifty percent of dialyzed patients and similar proportions of the
other groups considered their sexual potency to be decreased or
absent; 44% of all married men had not had intercourse in the
preceding week. Plasma testosterone was decreased in all three
groups: normal controls, 26.4 0.8 nmoles/liter (N = 17); non-
dialyzed, 16.9 2.5 nmoles/liter, P <0.001; dialyzed, 16.5 1.2
nmoles/Titer, P < 0.001; and transplanted patients 14.0 1.2
nmoles/liter, P < 0.001. Serum leutinizing hormone (LH) was
raised in all three groups, suggesting that the fundamental abnor-
mality was primary testicular failure. In 14 dialyzed patients, the
20-mm response to gonadotropin releasing hormone (GN-RH)
was exaggerated, confirming primary testicular failure. Plasma
testosterone correlated positively with potency assessed by
questionnaire (P < 0.001) in dialyzed subjects, suggesting
that inadequate androgenization was a cause of sexual dys-
function. Basal follicle-stimulating hormone (FSH) levels were
raised in the transplant recipients: normal laboratory range,
1 to 7 U/liter, transplanted patients, 10.7 U/liter (2.6 to >50),
P < 0.02. This suggested germ cell damage, probably re-
sulting from immunosuppressive therapy because FSH levels
were normal in most other patients. Simultaneous studies sug-
gested only a small role for autonomic dysfunction and psycho-
logic factors in sexual dysfunction. Zinc therapy. An important
role for zinc deficiency in the sexual dysfunction of dialyzed pa-
tients has been suggested by other authors. Serum zinc levels in
Newcastle patients were reduced: normal controls, 114.6 5.9
g/d1 (N = 13); nondialyzed, 83.7 3.7 g/dl, P < 0.01; dia-
lyzed, 86.3 5.2 zg/dl, P < 0.01; and transplanted patients, 84.6
4.5 ig/dl, P <0.01. Serum zinc correlated weakly with testicu-
lar volume (r = 0.551, P < 0.05), but not with any measure of
sexual function or endocrine status. A double-blind trial of zinc
repletion (N = 7) or placebo administration (N = 7) was per-
formed. Therapy was administered via the dialysis fluid for a 6-
week period. Nocturnal penile tumescence was measured by a
strain-gauge technique. This method has been shown to dif-
ferentiate between organic and psychogenic impotence; it con-
firmed that impotence in all our patients studied was organic.
Serum zinc levels were raised 16% by zinc administration. There
was no effect on questionnaire response, nocturnal erection,
plasma testosterone, LH, and FSH before and after Gn-RH. We
conclude that zinc deficiency is not of major importance in the
sexual dysfunction of dialyzed patients.
Studies on the significance of bacterial adherence in experimen-
tal urinary tract infection. S. Chick, M. J. Harber, R. Mackenzie,
A. W. Asscher, andD. B. Moffat. KR UF Institute of Renal Dis-
ease, Welsh National School of Medicine, Royal Infirmary, and
Department of Anatomy, University College, Cardiff, Wales.
Adherence of bacteria to mucosal surfaces is an important step in
their ability to produce infection. The present study was per-
formed to compare the ability of four strains of Escherichia coil
to adhere to bladder mucosa in vitro with their in vivo survival in
the rat urinary tract, and to investigate whether incubation in
2.5% u-mannose or alpha-methyl-D-mannoside (amm) will inter-
fere with this adherence. In vitro adherence was measured by
incubating strips of bladder mucosa in suspensions of bacteria,
